腹膜透析在肝硬化中的结果:系统性审查和元分析
Poemlarp Mekraksakit1, Supawadee Suppadungsuk1,2, Charat Thongprayoon1
1Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
概括
腹腔透析 (PD) 在末期脏病 (ESKD) 患者的肝硬化中提供与血液透析 (HD) 相似的死亡结果. 肝硬化不会显著增加PD患者的死亡风险,这表明PD是一种可行的治疗选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
背景情况:
- 末期病 (ESKD) 和肝硬化是全球主要的健康问题,死亡率高.
- 血液透析 (HD) 在肝硬化中常见于ESKD,但导致血液动力学不稳定.
- 腹膜透析 (PD) 不常用于肝硬化,因为腹膜炎和死亡率的担忧.
研究的目的:
- 系统地审查和对ESKD肝硬化患者的PD结果进行元分析.
- 为了比较肝硬化患者和非肝硬化患者的PD结果.
- 为了比较患有肝硬化的ESKD患者的PD与HD结局.
主要方法:
- 在Ovid MEDLINE,EMBASE和Cochrane数据库中进行了全面的搜索,截至2023年9月25日.
- 纳入了研究,检查了患有PD或HD肝硬化ESKD患者的死亡率和临床结果.
- 数据是使用随机效应模型和反变量方法进行元分析汇总的.
主要成果:
- 分析包括13项研究,涉及15089名患者.
- 在患有肝硬化的ESKD患者中,在PD和HD之间没有发现死亡率的显著差异 (OR 0.77).
- 患有肝硬化PD的肝硬化患者表现出膜炎 (OR 1.10) 和慢性低血压 (OR 17.50) 的风险较高,但死亡率与非肝硬化对照 (OR 1.05) 相比较.
结论:
- 腹膜透析 (PD) 是一个可行的治疗末期脏病 (ESKD) 在肝硬化患者.
- 在这个人群中,PD提供了与血液透析 (HD) 相似的死亡结果.
- 虽然低血压和腹膜炎等风险略有增加,但PD仍然是一个有效的选择.
相关概念视频
Dialysis
301
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
301
Heart Failure Drugs: Diuretics
367
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
Chronic Pancreatitis II: Collaborative Care
85
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
85
Pleural Effusion II: Symptoms and Management
165
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
165


